Next Article in Journal
The Presence of Toxic and Non-Toxic Cyanobacteria in the Sediments of the Limpopo River Basin: Implications for Human Health
Previous Article in Journal
Light Chain Diversity among the Botulinum Neurotoxins
Previous Article in Special Issue
Functional Characterization of the alb1 Orthologue Gene in the Ochratoxigenic Fungus Aspergillus carbonarius (AC49 strain)
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Toxins
Volume 10
Issue 7
10.3390/toxins10070270
toxins-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Antioxidant Gallic Acid Inhibits Aflatoxin Formation in Aspergillus flavus by Modulating Transcription Factors FarB and CreA

by
Xixi Zhao
1,†,
Qing-Qing Zhi
1,†,
Jie-Ying Li
1,
Nancy P. Keller
2,* and
Zhu-Mei He
1,*
1
The Guangdong Province Key Laboratory for Aquatic Economic Animals, School of Life Science, Sun Yat-sen University, Guangzhou 510275, China
2
Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, WI 53706, USA
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Toxins 2018, 10(7), 270; https://doi.org/10.3390/toxins10070270
Submission received: 12 June 2018 / Revised: 23 June 2018 / Accepted: 27 June 2018 / Published: 3 July 2018
(This article belongs to the Special Issue Functional Genomics of Toxigenic Fungi and Regulatory Mechanism in the Biosynthesis of Mycotoxins)
Browse Figures
Versions Notes

Abstract

:
Aflatoxin biosynthesis is correlated with oxidative stress and is proposed to function as a secondary defense mechanism to redundant intracellular reactive oxygen species (ROS). We find that the antioxidant gallic acid inhibits aflatoxin formation and growth in Aspergillus flavus in a dose-dependent manner. Global expression analysis (RNA-Seq) of gallic acid-treated A. flavus showed that 0.8% (w/v) gallic acid revealed two possible routes of aflatoxin inhibition. Gallic acid significantly inhibited the expression of farB, encoding a transcription factor that participates in peroxisomal fatty acid β-oxidation, a fundamental contributor to aflatoxin production. Secondly, the carbon repression regulator encoding gene, creA, was significantly down regulated by gallic acid treatment. CreA is necessary for aflatoxin synthesis, and aflatoxin biosynthesis genes were significantly downregulated in ∆creA mutants. In addition, the results of antioxidant enzyme activities and the lipid oxidation levels coupled with RNA-Seq data of antioxidant genes indicated that gallic acid may reduce oxidative stress through the glutathione- and thioredoxin-dependent systems in A. flavus.
Keywords:
Aspergillus flavus; antioxidant gallic acid; aflatoxin; farB; creA
Key Contribution: We found that the antioxidant gallic acid inhibits aflatoxin formation in A. flavus in a dose-dependent manner: The mechanism was suggested as being through the FarB-mediated β-oxidation and CreA activity, with some contribution from the pentose phosphate pathway.

1. Introduction

Aspergillus flavus is not only a saprotrophic and plant pathogenic fungus but also an opportunistic human and animal pathogen [1]. A. flavus is notorious for production of aflatoxins, which were discovered as the main cause of Turkey-X disease in the 1960s [2]. Since then, substantial efforts have been directed toward understanding the complex mechanisms and the regulation network of aflatoxin biosynthesis.
Primary metabolism has a close link with secondary metabolite synthesis in fungi and, in the case of aflatoxin, several studies have shown that β-oxidation contributes to high levels of aflatoxin. Fatty acid β-oxidation in both the peroxisome and mitochondria has a fundamental contribution to toxin production, such as the polyketides, aflatoxin, and sterigmatocystin [3]. Reverberi et al. treated A. flavus with bezafibrate, an inducer of peroxisomal β-oxidation in mammals, and stimulated aflatoxin production. They also introduced a P33 gene into A. flavus to induce peroxisome proliferation, which leads to an upregulation of lipid metabolism and higher content of intracellular reactive oxygen species (ROS), with increasing aflatoxin formation [4]. The metabolomic studies also demonstrated that the lack of aflatoxin formation in a known aflatoxin inhibitory medium (peptone) was accompanied with suppressed fatty acid synthesis and reduced tricarboxylic acid (TCA) cycle intermediates, and increased pentose phosphate pathway products [5]. The accumulating NADPH pool, derived primarily from the pentose phosphate pathway, was suggested to suppress aflatoxin synthesis by directing the acyl-CoA into lipid synthesis, rather than polyketide biosynthesis [6,7].
In addition to a requirement for adequate acyl-CoA pools to synthesize aflatoxin, several groups have proposed that oxidative stress is a prerequisite for aflatoxin biosynthesis in Aspergillus parasiticus [8,9,10]. This observation is tied in with the hypothesis that aflatoxin is a secondary defense system protecting the fungus from excess ROS [11]. Supporting these proposals are studies showing that compounds which altered oxidative stress in A. flavus or A. parasiticus also affected aflatoxin production. For example, the pro-oxidants cumene, hydroperoxide, and hydrogen peroxide promoted aflatoxin biosynthesis in A. flavus [4], and epoxides stimulated aflatoxin formation by increasing the lipid peroxidation in A. flavus and A. parasiticus [12]. Conversely, antioxidants, such as ethylene, alleviated the oxidative stress and changed the glutathione redox state in A. flavus, which resulted in inhibiting aflatoxin biosynthesis [13]. Lentinula edodes β-glucan significantly reduced aflatoxin formation in A. parasiticus by stimulating antioxidant enzyme activity, and the activation of antioxidant response-related transcription factors, which correlated with a delay of aflatoxin genes expression [14]. Piperine inhibited aflatoxin production in A. flavus concurrently with positive regulation of genes belonging to superoxide dismutase and catalase families, as well as genes encoding the basic leucine zipper (bZIP) transcription factors AtfA, AtfB, and Ap-1 [15]. These bZIP transcription factors and MsnA are thought to participate in a regulatory network that mediates both the oxidative stress and aflatoxin pathways in A. parasiticus [11].
Gallic acid (GA), a constituent in the pellicle of Tulare walnut, has shown potent inhibitory activity toward aflatoxin biosynthesis [16], but the mechanism of GA inhibition of aflatoxin formation has not been studied. We present here our finding that GA significantly inhibited the expression of the farB gene, which controls the activity of peroxisomal fatty acid β-oxidation [17], and of the carbon repression regulator encoding gene, creA, which has recently been found involved in aflatoxin synthesis [18]. Simultaneously, the expression of almost all assigned genes in the aflatoxin biosynthesis cluster was significantly downregulated by 0.8% (w/v) GA treatment. Our work provides insights into cellular mechanisms underlying oxidative stress responses contributing to aflatoxin biosynthesis in A. flavus.

2. Results

2.1. Effect of GA on Aflatoxin Biosynthesis and Growth in A. flavus

Treatment of A. flavus NRRL3357 spores with different concentrations (0, 0.2%, 0.5%, 0.8%, and 1%, w/v: Weight/volume) of GA showed that GA inhibited aflatoxin B1 synthesis in a dose-dependent manner (Figure 1). Aflatoxin B1 production was significantly inhibited when the GA concentration was 0.5% (w/v), and was totally inhibited with greater than 0.8% (w/v) GA in the medium. Aflatoxin reduction was positively correlated with a decrease in A. flavus colony diameter (Figure 2A,B), with the maximum inhibition rate of 24% in the 1% (w/v) treated samples at the 3rd-day cultivation (Table S1). However, when A. flavus was inoculated into liquid PDB medium, mycelial mass increased in the 1% (w/v) GA treated samples compared with the untreated samples (Figure 2C).
A sample of 107 spores was inoculated into 30 mL PDB with different concentration (0, 0.2%, 0.5%, 0.8%, 1%, w/v) of GA, cultured at 30 °C, 200 rpm. Next, 200 µL culture medium were taken out at 24 h, 48 h, and 72 h, respectively, for TLC analysis, AFB1: Aflatoxin B1 standard from Sigma. These were 0.2% GA: 0.2% (w/v) GA, 0.5% GA: 0.5% (w/v) GA, 0.8% GA: 0.8% (w/v) GA, 1% GA: 1% (w/v) GA. w/v: Weight/volume, such as 0.3 g GA add into 30 mL PDB medium will make a PDB+1% (w/v) GA.

2.2. Transcriptomic Profiles of A. flavus Responding to GA

In order to gain insight into the mechanism by which GA inhibits aflatoxin synthesis, RNA was extracted from 24 h cultures treated with either 0.2% (w/v) GA (partly inhibits aflatoxin B1 formation) or 0.8% (w/v) GA (totally inhibits aflatoxin B1 formation) for RNA-Seq analysis. Table S2 summarizes the RNA-Seq data. The FPKM [19] value had been applied to quantify the level of each genes’ expression, and the count number of each gene from the three sequenced samples were analyzed by DEseq software [20] for genes’ different expression analysis. The genes with |log2Ratio| ≥ 1 and q < 0.05 were considered as significantly differentially expressed and listed in Table S3. In total, 535 genes were significantly differentially transcribed between 0.2% (w/v) GA treated and untreated A. flavus samples, and 2040 significantly differentially expressed genes were found in 0.8% (w/v) GA treated compared with untreated A. flavus samples (Table 1). In addition, 361 shared genes were found in these two sets (Figure 3, Table S3).

2.3. Effect of GA on the Expression of Genes in A. flavus Secondary Metabolism Clusters

There are 56 predicted secondary metabolism gene clusters in A. flavus [21,22], most of which contain a gene encoding for a ‘backbone’ enzyme (e.g., PKS, NRPS, DMATs, terpene, etc) essential for their respective secondary metabolite biosynthesis [22]. The effect of GA on the A. flavus 56 secondary metabolism clusters activity was analyzed based on the ‘backbone’ genes expression in our RNA-Seq data, and the data showed that there were 16 secondary metabolism clusters significantly affected by GA treatment (Table S4). The cluster #54, responsible for the aflatoxin biosynthesis, was one of these 16 clusters, and almost all the assigned genes (except the regulatory genes aflR and aflS [23]) expression were significantly downregulated in the 0.8% (w/v) GA treated samples compared with the untreated samples (Figure 4, Table S3). These data are consistent with the 0.8% (w/v) GA totally inhibiting aflatoxin formation in A. flavus (Figure 1).

2.4. Expression Changes of the Developmental Regulatory Genes and the Primary Metabolic Genes in A. flavus in Response to GA

Because the genes encoding aflatoxin transcription factors aflR and aflS were not significantly affected by GA (Table S3), we next examined the RNA-seq for other clues as to why aflatoxin biosynthesis and gene expression were down regulated. We first looked at transcriptional regulators of aflatoxin. The Velvet Complex heterotrimer is a critical transcriptional complex required for secondary metabolism and fungal development in Aspergillus spp. [24], including A. flavus [25]. However, in our data, the expression of all three members, veA, velB, and laeA were not significantly different in the GA-treated A. flavus samples compared with the untreated A. flavus samples. We also observed that nsdC encoding a C2H2 zinc finger-type DNA-binding protein, which is required for normal sclerotia formation and aflatoxin biosynthesis in A. flavus [26], was upregulated (Table 2) and thus not a likely cause of loss of aflatoxin production by GA.
Carbon utilization pathways have also been associated with aflatoxin biosynthesis. In our RNA-Seq data, most of the putative genes responsible for the pentose phosphate pathway were upregulated by GA treatment, such as AFLA_086620, AFLA_080390, and AFLA_036840 (Table 2) encoding proteins homologous to Zwf1, Sol3, and Gnd1 in Candida albicans, respectively [27]. Pentose phosphate pathway activity has been linked to decreased aflatoxin synthesis in a previous study [5] and thus supports a possible role of this pathway in gallic acid repression of aflatoxin production.
Fatty acids and β-oxidation have been largely shown to promote aflatoxin biosynthesis [3,28]. The most striking finding from the RNA-seq data was the large number of peroxisome and fatty acid β-oxidation-related genes (Table S5) which were significantly and primarily down regulated by GA treatment based on the GO analysis (Table S6). These genes included the peroxisomal β-oxidation multifunctional enzyme encoding gene, foxA [29], and acetyl-carnitine transferase encoding gene, acuJ [30]. The fatty acid metabolism regulatory transcription factor gene, farB (AFLA_012010), was also downregulated. FarB has been reported as positively affecting aflatoxin biosynthesis in A. flavus via regulating the expression of the peroxisomal fatty acid β-oxidation-related genes pexK, foxA, and acuJ [17].
Finally, we noted that the carbon catabolite repression gene, creA [31], decreased with the increasing concentration of GA and was significantly downregulated in the 0.8% (w/v) GA-treated samples compared with the untreated samples (Table 2). CreA regulates gene expression, either directly by binding to the consensus binding sites (5′-SYGGRG-3′) in the promoter of the target genes [32], or through transcriptional cascades. This consensus binding site is found in 14 out of the 19 aflatoxin gene promoter regions (Table 3), and because expression of these genes (except aflR and aflS) was significantly downregulated by GA treatment, it appeared likely that GA regulation of creA was also contributing to the reduction of aflatoxin synthesis. Indeed we found that all 19 assigned aflatoxin genes were significantly downregulated in two independent ∆creA mutants compared with wild type (WT) (Figure 5). These results were consistent with the loss of aflatoxin synthesis in the deletion of creA in another strain of A. flavus, CA14 [18].

2.5. Effect of GA on Oxidative Stress Genes and the Antioxidant Enzymatic Activities

In A. flavus, there are several oxidative stress-related transcription factors that mediate oxidative stress and aflatoxin formation, and among these AtfA, AtfB, Ap-1, and MsnA have been characterized [33,34,35,36]. The expression of the genes encoding these transcription factors did not show significant difference in the GA-treated samples compared with the untreated samples. However, we found some of the enzymatic genes regulated by these transcription factors were differentially regulated, including the genes encoding the antioxidant enzymes catalase (AFLA_056170, AFLA_122110, and AFLA_090690) and superoxide dismutase (SOD, AFLA_099000, and AFLA_033420), which were slightly upregulated in the 0.8% (w/v) GA-treated samples compared with the untreated samples. Additionally, genes encoding the glutathione S-transferase and the thioredoxin system proteins presented significantly higher expression levels in the 0.8% (w/v) GA-treated samples compared with the untreated samples (Table 4). Oxylipin synthesis is associated with oxidative processes and aflatoxin biosynthesis and, as shown in Table 4, the ppoC gene encoding for oxylipin biosynthesis [37] and the GPCRs genes gprC, gprK, and gprM—implicated in oxylipin perception [38]—were significantly inhibited by at least one GA treatment.
To gain more information on this possible linkage of GA with oxidative processes, the activities of catalase and SOD and the level of Malondialdehyde (MDA, as a marker of lipid oxidation) were measured in the 0.2% (w/v) and 0.8% (w/v) GA-treated and untreated A. flavus samples with 24 h cultivation. Results, shown in Figure 6, demonstrated that the MDA content was decreased by GA treatment (Figure 6A), and the activities of catalase and SOD were also inhibited in the GA treated samples compared with the untreated samples (Figure 6B,C), despite a slight increase in gene expression. These results and the expression of the antioxidant genes indicate that GA may balance oxidative stress homeostasis in A. flavus via activating the glutathione- and thioredoxin-dependent antioxidant system, rather than through catalase and SOD activity.

3. Discussion

Upon finding that GA was effective in suppressing aflatoxin synthesis, Mahoney and Molyneux [16] suggested the mechanism might be through GA control of the fatty acid synthases (aflA, aflB) or polyketide synthase (aflC) required for generation of norsolorinic acid, the first visible and stable intermediate in the aflatoxin synthesis pathway [23], which accumulates in peroxisome [3]. In this study, we not only observe down-regulation of these genes, but also identify the cellular pathways which may be affecting regulation of these genes and aflatoxin synthesis in general. We demonstrated that GA inhibited aflatoxin biosynthesis in A. flavus in a dose-dependent manner, where aflatoxin formation was partly inhibited by 0.2% (w/v) GA treatment and totally inhibited by more than 0.8% (w/v) GA treatment. To find out the genes mediating GA and aflatoxin biosynthesis in A. flavus, the transcriptomic profile of the 0, 0.2%, and 0.8% (w/v) GA-treated A. flavus samples was obtained based on the RNA-Seq technology. Taken together, the transcriptional profiling results suggested GA could be suppressing aflatoxin synthesis through several cellular pathways that have already been implicated in aflatoxin regulation: One inhibitory (pentose phosphate pathway) and two stimulatory routes (FarB mediated β-oxidation and CreA activity). The expression changes of those genes in 0.2% (w/v) GA treatment is consistent with the partly inhibited aflatoxin formation in this treatment. Both the pentose phosphate pathway and β-oxidation pathway are active in the peroxisome, the site of the initial steps of aflatoxin biosynthesis [3]. Despite GA’s role as an antioxidant, the RNA-seq and physiological testing (Figure 6) were less clear on the role of antioxidant pathways in suppressing aflatoxin synthesis, although potential involvement of the glutathione- and thioredoxin-dependent antioxidant systems will be a future avenue to address. We also note that the antioxidant activity of the gallic acid molecule itself could be a contributing factor [39].
Aflatoxin molecular formation needs more than 23 enzymatic reactions [23] and at least 10 NADPHs [40], however, there is a competition for NADPH in acetyl-CoA incorporation into lipid synthesis, rather than into polyketides like aflatoxin [6]. In the toxin-supporting medium (Glucose-mineral salts medium, GMS), diminished NADPH generating capacity indicated that depressed NADPH/NADP ratios favor aflatoxin biosynthesis [41]. The two dehydrogenases (Zwf1 and Gnd1) in the oxidative branch of the pentose phosphate pathway, the main source of NADPH in the cell, are located in peroxisomes in Candida albicans [27]. The genes AFLA_086620 and AFLA_036840, encoding the homologous Zwf1 and Gnd1 proteins, respectively, were upregulated by GA treatment (Table 2), which indicated that GA treatment might regulate A. flavus intracellular NADPH pools and promote acyl-CoA incorporation into lipid synthesis, rather than polyketide production.
Acetyl-CoA is produced from the oxidative decarboxylation of pyruvate and fatty acid β-oxidation [40], and fatty acid β-oxidation is a fundamental contributor to polyketide mycotoxin (aflatoxin and sterigmatocystin) formation [3]. The fatty acid transcription factor FarB—which activates peroxisomal β-oxidation genes—has been shown to positively regulate aflatoxin production in A. flavus [17]. In our RNA-Seq data, most of the genes involved in fatty acid β-oxidation, including farB, were downregulated by GA treatment (Table S5). The transcript of farB, foxA (encoding the peroxisomal β-oxidation multifunctional enzyme), and acuJ (encoding carnitine acetyltransferase), were significantly decreased in the 0.8% (w/v) GA-treated samples compared to the untreated samples (Table 2). Suppression of the peroxisomal β-oxidation pathway genes by GA treatment would be expected to reduce acyl-CoA pools and inhibit aflatoxin formation through lack of precursors.
Aflatoxin biosynthesis is also closely associated with carbohydrate catabolism [41]. For example, glucose, sucrose, and fructose induced aflatoxin formation, while peptone and lactose did not support aflatoxin production [28,42]. Abdollahi et al. [28] suggested that the aflatoxin formation induced by these carbon sources was as a feedback regulation of the elevated energy state which was caused by the utilization of a readily-metabolizable carbohydrate. Microorganisms prefer utilizing the most favored carbon source with the mechanism of carbon repression, and the transcription factor CreA is a well-known as carbon repression regulator in Aspergillus [31]. In Aspergillus nidulans, CreA can regulate carbon utilization genes via directly binding to the consensus sequence 5′-SYGGRG-3′ in the promoter of these genes [32], and is critical for normal growth on carbon, nitrogen, and lipid sources [43]. The CreA consensus binding sites have been found in the promoter regions of 14 assigned aflatoxin genes (Table 3), and the expression of almost all the aflatoxin genes (except the regulator genes aflR and aflS) and the creA gene, AFLA_134680, were significantly suppressed by the 0.8% (w/v) GA treatment (Figure 4, Table 2). To confirm the hypothesis that CreA was involved in aflatoxin gene regulation, we deleted creA in A. flavus and the ∆creA mutants were unable to produce the mycotoxin. The qRT-PCR result showed that the expression of the aflatoxin genes were significantly down regulated in the ∆creA mutants compared to WT, which is consistent with an identical role for this protein in aflatoxin biosynthesis in another strain of A. flavus, CA14 [18]. Whether the regulation is direct via CreA binding of individual afl genes or indirect is still to be determined. In A. flavus, GprC was considered as a carbon sensing receptor [38] which may mediate the expression of carbon utilization genes. As the GprC encoding gene was significantly inhibited by 0.8% (w/v) GA treatment, we propose that GA may depress creA expression through GprC signaling. Taking these results together, we suggest that GA inhibits aflatoxin biosynthesis in A. flavus via modulating the expression of the FarB and CreA pathways, a hypothetical mechanism proposed in Figure 7.

4. Materials and Methods

4.1. Fungal Strain and Culture Conditions

Aspergillus flavus NRRL3357 [44], TJES20.1 (∆ku70, ∆argB::A. fumigatus pyrG, pyrG-) [45], and TJW149.27 (∆ku70::A. parasiticus pyrG, pyrG-) were used in this research. A total of 107 A. flavus NRRL3357 spores were inoculated into 30 mL PDB (BD Difco) with different concentrations (0, 0.2%, 0.5%, 0.8%, and 1% w/v) of GA, cultured at 30 °C, 200 rpm for aflatoxin analysis or mycelia weight measurement. A total of 103 spores were inoculated on PDA (BD Difco) medium with different concentrations (w/v) of GA and cultured at 30 °C for diameter determination. TJES20.1 was used for deleting creA gene in A. flavus, and TJW149.27 was used as control for creA mutants.

4.2. Aflatoxin Analysis and Measuring the A. flavus Colony Diameters and Mycelia Weights

Aflatoxin was extracted from 200 µL culture medium and analyzed by modified thin-layer chromatography (TLC) [46]. A total of 103 A. flavus spores were point-inoculated on PDA medium with different concentrations of GA, the plates were cultured at 30 °C incubator, and the diameters were measured on different culture days. To investigate the effect of GA on A. flavus mycelia growth, 107 A. flavus spores were inoculated into 30 mL PDB medium with or without 1% (w/v) GA, and cultured at 30 °C, 200 rpm. The mycelia were collected by using vacuum filtration and measured by analytical balance (0.0001 g) after drying in the oven.

4.3. RNA Extraction and cDNA Library Preparation for RNA-Seq Analysis

Triplicate cultures of 107 A. flavus spores were grown in PDB medium with 0, 0.2%, and 0.8% (w/v) GA, respectively, at 30 °C, 200 rpm, harvested after 24 h, and ground in a mortar and pestle under liquid nitrogen. TRIzol reagent (Invitrogen, Carlsbad, CA, USA) was used to extract total RNA from ground mycelia, according to the manufacturer’s instructions. Library construction and RNA quality analysis for all nine samples were conducted by Annoroad (Beijing, China). The Agilent 2100 bioanalyzer with Agilent RNA 6000 Nano Kit (Agilent Technologies, Santa Clara, CA, USA) was used to assess the integrity and purity of the RNA samples. All samples had an RNA Integrity Number (RIN) with more than 8.0. The cDNA library construction was conducted as follows: The mRNA was purified by using Oligo (dT)-attached magnetic beads and fragmented into small pieces by Fragmentation Buffer. The fragmented mRNA was copied into first strand cDNA using random hexamer primers, then the dNTPs, RNase H, and DNA polymerase I were added into the reactions to get the second strand cDNA. These cDNA fragments were purified with QIAQuick PCR kit and eluted with elution buffer, then these cDNA fragments were treated through an end repair process, an addition of a single ‘A’ base, and then ligation of the sequencing adapters. Finally, the cDNA library was sequenced on the Illumina HiSeq platform.

4.4. Data Analysis and Normalizing the Expression Levels of Genes

After removing the reads adapters, low quality reads, and reads with more than 5% N, the remaining reads were mapped to the A. flavus NRRL3357 genome (https://www.ncbi.nlm.nih.gov/nuccore/AAIH00000000.2) by using TopHat v2.0.12 [47] and Bowtie2 [48] software. The Fragments per Kilobase per Million Mapped Fragments (FPKM) [19] was used to normalize the expression levels of the genes in these sequenced samples. The mean value of the count number of each gene from the three sequenced samples were analyzed by DEseq software [20] for genes’ different expression analysis, the genes from each compared sample with |log2Ratio| ≥ 1 and q < 0.05 were considered as significantly differentially expressed between these compared samples. GO analysis was done by Blast2GO software. The transcriptomic profile of the detectable genes in this research can be found in Table S3.

4.5. creA Mutant Construction and qRT-PCR Analysis

All primers used for creA mutant construction are listed in Table S7. The homologous recombination technology was used to create a creA mutant [45]. All PCR-generated flanks ranged in size around 1.5 kb, argB with its own promotor and terminator from A. flavus and wild type genomic DNA was used as the marker gene. The transformation construct for creA mutant was made by double joint PCR [49] and transformed into the parental strain TJES20.1 (∆ku70, ∆argB::Aspergillus fumigatus pyrG, pyrG-). Transformation of fungal strains was carried out according to the protocol of Szewczyk et al. [50], with some modifications that can be found in Zhao et al. [51]. The creA mutants were confirmed by PCR and qRT-PCR (Figure S1A,B), and aflatoxin synthesis of creA mutants (Figure S1C) was analyzed by TLC, the primers for qRT-PCR can be found in Table S7. A total of 107 spores of WT, ∆creA-1, and ∆creA-2 were inoculated into 30 mL PDB medium, and cultured at 200 rpm, 30 °C for 3 days, and the mycelia were collected for RNA extraction. RNA was extracted by Trizol (Invitrogen, Carlsbad, CA, USA) following the manufacturer’s instructions. RNA quality and quantity were measured by NanoVue plus (GE Healthcare, Buckinghamshire, UK). Reverse transcription was carried out by HiScriptIIQ RT SuperMix (Vazyme, Nanjing, China) for qRT-PCR.

4.6. Antioxidant Enzymatic Activities and the Lipid Oxidation Level Measurement

In order to observe the impact of GA on the antioxidant system activities in A. flavus, superoxide dismutase (SOD), catalase (CAT), and the content of Malondialdehyde (MDA) were performed on 24 h cultures, following the same culture conditions of RNA isolation.
Around 300 mg mycelium were suspended in 800 µL PBS buffer and homogenized by Tissuelyser® (Jingxin industrial development Co., Shanghai, China). Then samples were centrifuged at 12,000 rpm for 10 min at 4 °C, the supernatants were used for measuring the enzymes activities, MDA content, and protein concentrations. The catalase assay kit (S0051) and total superoxide dismutase assay kit with WST-8 (S0101) were used to measure the enzymes activities, the MDA content was determined using lipid peroxidation MDA assay kit (S0131), and protein concentrations were measured using an enhanced BCA protein assay kit (P0010). All these measurements were conducted according to manufacturer’s instructions, and these kits were bought from Beyotime Biotechnology (Beijing, China). The enzymatic activities and MDA content were normalized according to their protein concentrations.

4.7. Statistical Analysis

All the wet-lab experiments were conducted in triplicate. The GraphPad Prism software (La Jolla, CA, USA) was used for statistical analysis. Statistically significant differences were determined by an unpaired Student’s t-test with a two-tailed distribution and p < 0.05. The error bars in all figures indicate the standard error of the mean.

Supplementary Materials

The following are available online at https://www.mdpi.com/2072-6651/10/7/270/s1, Table S1: The inhibition rate and significance analysis of gallic acid on A. flavus growth. Table S2: Summary of the RNA-Seq data. Table S3: The transcriptomic profile of the detectable genes and the significantly differentially expressed genes. Table S4: The backbone genes of the 56 secondary metabolism clusters. Table S5: The genes enriched in peroxisome and fatty acid β-oxidation based on the GO analysis. Table S6: The GO data in this research. Table S7: Primers used to create creA mutants and for qRT-PCR analysis. Figure S1: Confirmation of the creA mutants and the aflatoxin formation in creA mutants.

Author Contributions

X.Z. and Z.-M.H. designed the experiments, N.P.K. supervised the data analysis, X.Z., N.P.K. and Z.-M.H. wrote the paper. X.Z. and Q.-Q.Z. performed all the experiments, J.-Y.L. contributed to the RNA extraction and other experiments. All authors read and approved the final manuscript.

Funding

This research received no external funding.

Acknowledgments

This work was supported in part by the National Natural Science Foundation of China (Grant No. 31470198), the Science and Technology Planning Project of Guangdong Province, China (Grant No. 2016B020204001), and the Science and Technology Planning Project of Guangzhou City, China (Grant No. 201510010158) to Z.M.H. and in part by support by the Food Research Institute to N.P.K.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Amaike, S.; Keller, N.P. Aspergillus flavus. Annu. Rev. Phytopathol. 2011, 49, 107–133. [Google Scholar] [CrossRef] [PubMed]
  2. Nesbitt, B.F.; O’Kelly, J.; Sargeant, K.; Sheridan, A. Aspergillus flavus and turkey X disease. Toxic metabolites of Aspergillus flavus. Nature 1962, 195, 1062–1063. [Google Scholar] [CrossRef] [PubMed]
  3. Maggio-Hall, L.A.; Wilson, R.A.; Keller, N.P. Fundamental contribution of β-oxidation to polyketide mycotoxin production in planta. Mol. Plant Microbe Interact. 2005, 18, 783–793. [Google Scholar] [CrossRef] [PubMed]
  4. Reverberi, M.; Punelli, M.; Smith, C.A.; Zjalic, S.; Scarpari, M.; Scala, V.; Cardinali, G.; Aspite, N.; Pinzari, F.; Payne, G.A.; et al. How peroxisomes affect aflatoxin biosynthesis in Aspergillus flavus. PLoS ONE 2012, 7, e48097. [Google Scholar] [CrossRef] [PubMed]
  5. Yan, S.; Liang, Y.; Zhang, J.; Liu, C.M. Aspergillus flavus grown in peptone as the carbon source exhibits spore density- and peptone concentration-dependent aflatoxin biosynthesis. BMC Microbiol. 2012, 12, 106. [Google Scholar] [CrossRef] [PubMed]
  6. Kiser, R.C.; Niehaus, W.G. Purification and kinetic characterization of mannitol-1-phosphate dehydrogenase from Aspergillus niger. Arch. Biochem. Biophys. 1981, 211, 613–621. [Google Scholar] [CrossRef]
  7. Niehaus, W.G.; Dilts, R.P. Purification and characterization of mannitol dehydrogenase from Aspergillus parasiticus. J. Bacteriol. 1982, 151, 243–250. [Google Scholar] [PubMed]
  8. Jayashree, T.; Subramanyam, C. Oxidative stress as a prerequisite for aflatoxin production by Aspergillus parasiticus. Free Radic. Biol. Med. 2000, 29, 981–985. [Google Scholar] [CrossRef]
  9. Reverberi, M.; Zjalic, S.; Ricelli, A.; Fabbri, A.A.; Fanelli, C. Oxidant/antioxidant balance in Aspergillus parasiticus affects aflatoxin biosynthesis. Mycotoxin Res. 2006, 22, 39–47. [Google Scholar] [CrossRef] [PubMed]
  10. Narasaiah, K.V.; Sashidhar, R.B.; Subramanyam, C. Biochemical analysis of oxidative stress in the production of aflatoxin and its precursor intermediates. Mycopathologia 2006, 162, 179–189. [Google Scholar] [CrossRef] [PubMed]
  11. Hong, S.Y.; Roze, L.V.; Wee, J.; Linz, J.E. Evidence that a transcription factor regulatory network coordinates oxidative stress response and secondary metabolism in aspergilli. Microbiologyopen 2013, 2, 144–160. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Fanelli, C.; Fabbri, A.A.; Finotti, E.; Passi, S. Stimulation of aflatoxin biosynthesis by lipophilic epoxides. J. Gen. Microbiol. 1983, 129, 1721–1723. [Google Scholar] [CrossRef] [PubMed]
  13. Huang, J.Q.; Jiang, H.F.; Zhou, Y.Q.; Lei, Y.; Wang, S.Y.; Liao, B.S. Ethylene inhibited aflatoxin biosynthesis is due to oxidative stress alleviation and related to glutathione redox state changes in Aspergillus flavus. Int. J. Food Microbiol. 2009, 130, 17–21. [Google Scholar] [CrossRef] [PubMed]
  14. Reverberi, M.; Fabbri, A.A.; Zjalic, S.; Ricelli, A.; Punelli, F.; Fanelli, C. Antioxidant enzymes stimulation in Aspergillus parasiticus by Lentinula edodes inhibits aflatoxin production. Appl. Microbiol. Biotechnol. 2005, 69, 207–215. [Google Scholar] [CrossRef] [PubMed]
  15. Caceres, I.; El Khoury, R.; Bailly, S.; Oswald, I.P.; Puel, O.; Bailly, J.D. Piperine inhibits aflatoxin B1 production in Aspergillus flavus by modulating fungal oxidative stress response. Fungal Genet. Biol. 2017, 107, 77–85. [Google Scholar] [CrossRef] [PubMed]
  16. Mahoney, N.; Molyneux, R.J. Phytochemical inhibition of aflatoxigenicity in Aspergillus flavus by constituents of walnut (Juglans regia). J. Agric. Food Chem. 2004, 52, 1882–1889. [Google Scholar] [CrossRef] [PubMed]
  17. Luo, X.; Affeldt, K.J.; Keller, N.P. Characterization of the far transcription factor family in Aspergillus flavus. G3 2016, 6, 3269–3281. [Google Scholar] [CrossRef] [PubMed]
  18. Fasoyin, O.E.; Wang, B.; Qiu, M.; Han, X.; Chung, K.R.; Wang, S. Carbon catabolite repression gene creA regulates morphology, aflatoxin biosynthesis and virulence in Aspergillus flavus. Fungal Genet. Biol. 2018, 115, 41–51. [Google Scholar] [CrossRef] [PubMed]
  19. Trapnell, C.; Williams, B.A.; Pertea, G.; Mortazavi, A.; Kwan, G.; van Baren, M.J.; Salzberg, S.L.; Wold, B.J.; Pachter, L. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 2010, 28, 511–515. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Anders, S.; Huber, W. Differential expression analysis for sequence count data. Genome Biol. 2010, 11, R106. [Google Scholar] [CrossRef] [PubMed]
  21. Amare, M.G.; Keller, N.P. Molecular mechanisms of Aspergillus flavus secondary metabolism and development. Fungal Genet. Biol. 2014, 66, 11–18. [Google Scholar] [CrossRef] [PubMed]
  22. Georgianna, D.R.; Fedorova, N.D.; Burroughs, J.L.; Dolezal, A.L.; Bok, J.W.; Horowitz-Brown, S.; Woloshuk, C.P.; Yu, J.; Keller, N.P.; Payne, G.A. Beyond aflatoxin: Four distinct expression patterns and functional roles associated with Aspergillus flavus secondary metabolism gene clusters. Mol. Plant Pathol. 2010, 11, 213–226. [Google Scholar] [CrossRef] [PubMed]
  23. Yu, J.; Chang, P.K.; Ehrlich, K.C.; Cary, J.W.; Bhatnagar, D.; Cleveland, T.E.; Payne, G.A.; Linz, J.E.; Woloshuk, C.P.; Bennett, J.W. Clustered pathway genes in aflatoxin biosynthesis. Appl. Environ. Microbiol. 2004, 70, 1253–1262. [Google Scholar] [CrossRef] [PubMed]
  24. Bayram, O.; Krappmann, S.; Ni, M.; Bok, J.W.; Helmstaedt, K.; Valerius, O.; Braus-Stromeyer, S.; Kwon, N.J.; Keller, N.P.; Yu, J.H.; et al. VelB/VeA/LaeA complex coordinates light signal with fungal development and secondary metabolism. Science. 2008, 320, 1504–1506. [Google Scholar] [CrossRef] [PubMed]
  25. Amaike, S.; Keller, N.P. Distinct roles for VeA and LaeA in development and pathogenesis of Aspergillus flavus. Eukaryot. Cell 2009, 8, 1051–1060. [Google Scholar] [CrossRef] [PubMed]
  26. Cary, J.W.; Harris-Coward, P.Y.; Ehrlich, K.C.; Mack, B.M.; Kale, S.P.; Larey, C.; Calvo, A.M. NsdC and NsdD affect Aspergillus flavus morphogenesis and aflatoxin production. Eukaryot. Cell 2012, 11, 1104–1111. [Google Scholar] [CrossRef] [PubMed]
  27. Strijbis, K.; van den Burg, J.; Visser, W.F.; van den Berg, M.; Distel, B. Alternative splicing directs dual localization of Candida albicans 6-phosphogluconate dehydrogenase to cytosol and peroxisomes. FEMS Yeast Res. 2012, 12, 61–68. [Google Scholar] [CrossRef] [PubMed]
  28. Abdollahi, A.; Buchanan, R.L. Regulation of aflatoxin biosynthesis: Induction of aflatoxin production by various carbohydrates. J. Food Sci. 1981, 46, 633–635. [Google Scholar] [CrossRef]
  29. Maggio-Hall, L.A.; Keller, N.P. Mitochondrial β-oxidation in Aspergillus nidulans. Mol. Microbiol. 2004, 54, 1173–1185. [Google Scholar] [CrossRef] [PubMed]
  30. Midgley, M. Carnitine acetyltransferase is absent from acuJ mutants of Aspergillus nidulans. FEMS Microbiol. Lett. 1993, 108, 7–10. [Google Scholar] [CrossRef] [PubMed]
  31. Ruijter, G.J.; Visser, J. Carbon repression in Aspergilli. FEMS Microbiol. Lett. 1997, 151, 103–114. [Google Scholar] [CrossRef] [PubMed]
  32. Cubero, B.; Scazzocchio, C. Two different, adjacent and divergent zinc finger binding sites are necessary for CREA-mediated carbon catabolite repression in the proline gene cluster of Aspergillus nidulans. EMBO J. 1994, 13, 407–415. [Google Scholar] [PubMed]
  33. Balázs, A.; Pócsi, I.; Hamari, Z.; Leiter, É.; Emri, T.; Miskei, M.; Oláh, J.; Tóth, V.; Hegedűs, N.; Prade, R.A.; et al. AtfA bZIP-type transcription factor regulates oxidative and osmotic stress responses in Aspergillus nidulans. Mol. Genet. Genomics 2010, 283, 289–303. [Google Scholar] [CrossRef] [PubMed]
  34. Sakamoto, K.; Arima, T.; Iwashita, K.; Yamada, O.; Gomi, K.; Akita, O. Aspergillus oryzae atfB encodes a transcription factor required for stress tolerance in conidia. Fungal Genet. Biol. 2008, 45, 922–932. [Google Scholar] [CrossRef] [PubMed]
  35. Toone, W.M.; Morgan, B.A.; Jones, N. Redox control of AP-1-like factors in yeast and beyond. Oncogene 2001, 20, 2336–2346. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Chang, P.K.; Scharfenstein, L.L.; Luo, M.; Mahoney, N.; Molyneux, R.J.; Yu, J.; Brown, R.L.; Campbell, B.C. Loss of msnA, a putative stress regulatory gene, in Aspergillus parasiticus and Aspergillus flavus increased production of conidia, aflatoxins and kojic acid. Toxins 2011, 3, 82–104. [Google Scholar] [CrossRef] [PubMed]
  37. Brown, S.H.; Scott, J.B.; Bhaheetharan, J.; Sharpee, W.C.; Milde, L.; Wilson, R.A.; Keller, N.P. Oxygenase coordination is required for morphological transition and the host–fungus interaction of Aspergillus flavus. Mol. Plant Microbe Interact. 2009, 22, 882–894. [Google Scholar] [CrossRef] [PubMed]
  38. Affeldt, K.J.; Carrig, J.; Amare, M.; Keller, N.P. Global survey of canonical Aspergillus flavus G protein-coupled receptors. mBio 2014, 5, e01501-14. [Google Scholar] [CrossRef] [PubMed]
  39. Badhani, B.; Sharma, N.; Kakkar, R. Gallic acid: A versatile antioxidant with promising therapeutic and industrial applications. RSC Adv. 2015, 5, 27540–27557. [Google Scholar] [CrossRef]
  40. Yabe, K.; Nakajima, H. Enzyme reactions and genes in aflatoxin biosynthesis. Appl. Microbiol. Biotechnol. 2004, 64, 745–755. [Google Scholar] [CrossRef] [PubMed]
  41. Buchanan, R.L.; Lewis, D.F. Regulation of aflatoxin biosynthesis: Effect of glucose on activities of various glycolytic enzymes. Appl. Environ. Microbiol. 1984, 48, 306–310. [Google Scholar] [PubMed]
  42. Davis, N.D.; Diener, U.L. Growth and aflatoxin production by Aspergillus parasiticus from various carbon sources. Appl. Microbiol. 1968, 16, 158–159. [Google Scholar] [PubMed]
  43. Ries, L.N.A.; Beattie, S.R.; Espeso, E.A.; Cramer, R.A.; Goldman, G.H. Diverse regulation of the CreA carbon catabolite repressor in Aspergillus nidulans. Genetics 2016, 203, 335–352. [Google Scholar] [CrossRef] [PubMed]
  44. Payne, G.A.; Widstrom, N.W. Aflatoxin in maize. Crit. Rev. Plant Sci. 1992, 10, 423–440. [Google Scholar] [CrossRef]
  45. Pfannenstiel, B.T.; Zhao, X.; Wortman, J.; Wiemann, P.; Throckmorton, K.; Spraker, J.E.; Soukup, A.A.; Luo, X.; Lindner, D.L.; Lim, F.Y.; et al. Revitalization of a forward genetic screen identifies three new regulators of fungal secondary metabolism in the genus Aspergillus. mBio 2017, 8, e01246-17. [Google Scholar] [CrossRef] [PubMed]
  46. Lin, J.Q.; Zhao, X.X.; Wang, C.C.; Xie, Y.; Li, G.H.; He, Z.M. 5-Azacytidine inhibits aflatoxin biosynthesis in Aspergillus flavus. Ann. Microbiol. 2013, 63, 763–769. [Google Scholar] [CrossRef]
  47. Trapnell, C.; Pachter, L.; Salzberg, S.L. TopHat: Discovering splice junctions with RNA-Seq. Bioinformatics 2009, 25, 1105–1111. [Google Scholar] [CrossRef] [PubMed]
  48. Langmead, B.; Trapnell, C.; Pop, M.; Salzberg, S.L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009, 10, R25. [Google Scholar] [CrossRef] [PubMed]
  49. Lim, F.Y.; Sanchez, J.F.; Wang, C.C.C.; Keller, N.P. Toward awakening cryptic secondary metabolite gene clusters in filamentous fungi. Methods Enzymol. 2012, 517, 303–324. [Google Scholar] [CrossRef] [PubMed]
  50. Szewczyk, E.; Nayak, T.; Oakley, C.E.; Edgerton, H.; Xiong, Y.; Taheri-Talesh, N.; Osmani, S.A.; Oakley, B.R. Fusion PCR and gene targeting in Aspergillus nidulans. Nat. Protoc. 2007, 1, 3111–3120. [Google Scholar] [CrossRef] [PubMed]
  51. Zhao, X.; Spraker, J.E.; Bok, J.W.; Velk, T.; He, Z.M.; Keller, N.P. A cellular fusion cascade regulated by LaeA is required for sclerotial development in Aspergillus flavus. Front. Microbiol. 2017, 8, 1925. [Google Scholar] [CrossRef] [PubMed]
Toxins 10 00270 g001 550
Figure 1. Gallic acid (GA) inhibits aflatoxin biosynthesis in Aspergillus flavus in a dose-dependent manner.
Figure 1. Gallic acid (GA) inhibits aflatoxin biosynthesis in Aspergillus flavus in a dose-dependent manner.
Toxins 10 00270 g001
Toxins 10 00270 g002 550
Figure 2. GA affects A. flavus growth. (A) 103 spores were inoculated on PDA medium with different concentrations (w/v) of GA and cultured at 30 °C, the diameters were measured on different culture days. (B) The photo of the samples on the 7th day cultivation. (C) 107 spores were inoculated into 30 mL PDB with or without 1% (w/v) GA and cultured at 200 rpm, 30 °C for different days, then the mycelia were collected and measured. Each treatment has three replicates, *: p < 0.05, **: p < 0.01, ***: p < 0.001.
Figure 2. GA affects A. flavus growth. (A) 103 spores were inoculated on PDA medium with different concentrations (w/v) of GA and cultured at 30 °C, the diameters were measured on different culture days. (B) The photo of the samples on the 7th day cultivation. (C) 107 spores were inoculated into 30 mL PDB with or without 1% (w/v) GA and cultured at 200 rpm, 30 °C for different days, then the mycelia were collected and measured. Each treatment has three replicates, *: p < 0.05, **: p < 0.01, ***: p < 0.001.
Toxins 10 00270 g002
Toxins 10 00270 g003 550
Figure 3. Venn diagram of the significantly differentially expressed genes. In total, 361 genes were shared in these two sets, of which 185 were upregulated. P02_P: Significantly differentially expressed genes between 0.2% (w/v) gallic acid-treated and untreated A. flavus samples. P08_P: Significantly differentially expressed genes between 0.8% (w/v) gallic acid-treated and untreated A. flavus samples.
Figure 3. Venn diagram of the significantly differentially expressed genes. In total, 361 genes were shared in these two sets, of which 185 were upregulated. P02_P: Significantly differentially expressed genes between 0.2% (w/v) gallic acid-treated and untreated A. flavus samples. P08_P: Significantly differentially expressed genes between 0.8% (w/v) gallic acid-treated and untreated A. flavus samples.
Toxins 10 00270 g003
Toxins 10 00270 g004 550
Figure 4. Effect of GA on the expression of the aflatoxin assigned genes in A. flavus. P: Untreated A. flavus samples, P02: 0.2% (w/v) GA treated A. flavus samples, P08: 0.8% (w/v) GA treated A. flavus samples. P02_P Ratio: The mean value of the count number of each gene in P02/in P. P08_P Ratio: The mean value of the count number of each gene in P08/in P.
Figure 4. Effect of GA on the expression of the aflatoxin assigned genes in A. flavus. P: Untreated A. flavus samples, P02: 0.2% (w/v) GA treated A. flavus samples, P08: 0.8% (w/v) GA treated A. flavus samples. P02_P Ratio: The mean value of the count number of each gene in P02/in P. P08_P Ratio: The mean value of the count number of each gene in P08/in P.
Toxins 10 00270 g004
Toxins 10 00270 g005 550
Figure 5. Expression ratios of the aflatoxin biosynthesis-assigned genes in the ∆creA mutants compared to wild type WT(TJW149.27). A total of 107 spores of WT, ∆creA-1, and ∆creA-2 were inoculated into 30 mL PDB medium, and cultured at 200 rpm, 30 °C for 3 days, the mycelia was collected for RNA extraction, then the RNA was reverse transcript into cDNA for qRT-PCR analysis. The primers for the qRT-PCR can be found in Table S7. The expression of each gene in the WT was normalized as 1.0, each sample has three replicates, and the error bars indicate the standard error of the mean.
Figure 5. Expression ratios of the aflatoxin biosynthesis-assigned genes in the ∆creA mutants compared to wild type WT(TJW149.27). A total of 107 spores of WT, ∆creA-1, and ∆creA-2 were inoculated into 30 mL PDB medium, and cultured at 200 rpm, 30 °C for 3 days, the mycelia was collected for RNA extraction, then the RNA was reverse transcript into cDNA for qRT-PCR analysis. The primers for the qRT-PCR can be found in Table S7. The expression of each gene in the WT was normalized as 1.0, each sample has three replicates, and the error bars indicate the standard error of the mean.
Toxins 10 00270 g005
Toxins 10 00270 g006 550
Figure 6. Effect of GA on lipid oxidant (A) and antioxidant enzymes activities (B,C) in A. flavus. P: Untreated A. flavus samples, P02: 0.2% (w/v) GA-treated A. flavus samples, P08: 0.8% (w/v) GA-treated A. flavus samples. **: p < 0.01, ***: p < 0.001. MDA = Malondialdehyde, SOD = super oxide dismutase.
Figure 6. Effect of GA on lipid oxidant (A) and antioxidant enzymes activities (B,C) in A. flavus. P: Untreated A. flavus samples, P02: 0.2% (w/v) GA-treated A. flavus samples, P08: 0.8% (w/v) GA-treated A. flavus samples. **: p < 0.01, ***: p < 0.001. MDA = Malondialdehyde, SOD = super oxide dismutase.
Toxins 10 00270 g006
Toxins 10 00270 g007 550
Figure 7. Hypothetical mechanism of gallic acid (GA) inhibition of aflatoxin biosynthesis in A. flavus. GA inhibits (i) the expression of creA, which leads to the downregulation of the aflatoxin (AF) cluster genes, simultaneously GA (ii) reduces the peroxisomal fatty acids β-oxidation level by diminishing the expression of farB, resulting in decreasing the aflatoxin precursor acyl-CoA pools, and (iii) increasing the NADPH level via the pentose phosphate pathway, which favors lipid synthesis over aflatoxin biosynthesis in A. flavus. PM: Plasma membrane. The orange downward arrows indicate the expression of the genes that were significantly downregulated by GA treatment, the yellow upward arrows indicate the higher activity of the pentose phosphate pathway, which leads to increasing NADPH pools. Dotted lines indicate possible connecting pathways and solid lines indicate known pathways.
Figure 7. Hypothetical mechanism of gallic acid (GA) inhibition of aflatoxin biosynthesis in A. flavus. GA inhibits (i) the expression of creA, which leads to the downregulation of the aflatoxin (AF) cluster genes, simultaneously GA (ii) reduces the peroxisomal fatty acids β-oxidation level by diminishing the expression of farB, resulting in decreasing the aflatoxin precursor acyl-CoA pools, and (iii) increasing the NADPH level via the pentose phosphate pathway, which favors lipid synthesis over aflatoxin biosynthesis in A. flavus. PM: Plasma membrane. The orange downward arrows indicate the expression of the genes that were significantly downregulated by GA treatment, the yellow upward arrows indicate the higher activity of the pentose phosphate pathway, which leads to increasing NADPH pools. Dotted lines indicate possible connecting pathways and solid lines indicate known pathways.
Toxins 10 00270 g007
Table
Table 1. Summary of the significantly differentially expressed genes among the three samples.
Table 1. Summary of the significantly differentially expressed genes among the three samples.
Sample NameP02_PP08_P
Up271764
Down2641276
Total5352040
P02_P: 0.2% (w/v) GA treated samples (P02) compared with untreated samples (P), P08_P: 0.8% (w/v) GA treated samples (P08) compared with untreated samples (P). Up/Down: Genes’ expression was significantly upregulated/downregulated in the samples before the dash, Total: All the significantly differentially expressed genes between the compared samples.
Table
Table 2. Effect of gallic acid (GA) treatment on the expression of the transcription factor genes and primary metabolites related genes in Aspergillus flavus.
Table 2. Effect of gallic acid (GA) treatment on the expression of the transcription factor genes and primary metabolites related genes in Aspergillus flavus.
P02-P aP08-P b
Gene NameLog2 Ratio cp ValueUp/DownSignificant eLog2 Ratio dp ValueUp/DownSignificant e
veA
(AFLA_066460)		−0.44700.6546downno−0.39152.64 × 10−1downno
laeA
(AFLA_033290)		−0.29870.8134downno−0.69691.71 × 10−2downno
velB
(AFLA_081490)		0.93310.1439upno0.06359.35 × 10−1upno
brlA
(AFLA_082850)		−2.55800.0010downyes−2.33439.88 × 10−6downyes
NsdC
(AFLA_131330)		1.68880.0091upyes1.14643.45 × 10−5upyes
creA
(AFLA_134680)		−0.33670.8277downno−1.14869.15 × 10−8downyes
farB
(AFLA_012010)		−0.77990.4354downno−1.51904.81 × 10−5downyes
foxA
(AFLA_041590)		−0.51390.6420downno−1.15891.71 × 10−5downyes
AcuJ
(AFLA_135240)		−0.81480.2928downno−1.29981.85 × 10−5downyes
PexK
(AFLA_036410)		−0.75190.3792downno−0.85242.72 × 10−4downno
zwf1
(AFLA_086620)		0.64120.4931upno0.75906.7 × 10−3upno
sol3
(AFLA_080390)		0.21100.8837upno1.09911.0 × 10−4upyes
gnd1
(AFLA_036840)		0.37180.7936upno0.90721.3 × 10−3upno
a: 0.2% (w/v) GA-treated samples (P02) compared with the untreated samples (P). b: 0.8% (w/v) GA-treated samples (P08) compared with the untreated samples (P). c: The mean value of the count number of each gene in P02/in P. d: The mean value of the count number of each gene in P08/in P. e: The genes with |Log2 ratio| ≥ 1 and p value < 0.05 were considered as significantly differentially expressed, described as ‘yes’, otherwise described as ‘no’.
Table
Table 3. Presence of the CreA consensus binding motif (5′-SYGGRG-3′) in the aflatoxin biosynthesis genes promotor region.
Table 3. Presence of the CreA consensus binding motif (5′-SYGGRG-3′) in the aflatoxin biosynthesis genes promotor region.
Gene NameCreA Binding Motif
(5′-SYGGRG-3′) a		Position Relative to Start CodonDescription
AFLA_139190GTGGAG−361aflK/vbs/VERB synthase
AFLA_139200CTGGAG−795aflQ/ordA/ord-1/oxidoreductase/cytochrome P450 monooxigenase
AFLA_139210No motif found aflP/omtA/omt-1/O-methyltransferase A
AFLA_139220GTGGGG−1201aflO/omtB/dmtA/O-methyltransferase B
AFLA_139230CTGGGG/CCGGAG/GCGGAG−355/−398/−301aflI/avfA/cytochrome P450 monooxygenase
AFLA_139250CTGGGG−238aflL/verB/desaturase/P450 monooxygenase
AFLA_139260CTGGGG/GCGGAG−365/−810aflG/avnA/ord-1/cytochrome P450 monooxygenase
AFLA_139280No motif found aflN/verA/monooxygenase
AFLA_139300No motif found aflM/ver-1/dehydrogenase/ketoreductase
AFLA_139310CTGGGG/GCGGAG−482/−617aflE/norA/aad/adh-2/NOR reductase/dehydrogenase
AFLA_139320CCGGGG/CTGGGG−387/−299aflJ/estA/esterase
AFLA_139330GTGGGG/GCGGAG−488/−58aflH/adhA/short chain alcohol dehydrogenase
AFLA_139340GTGGAG/CCGGGG−737/−762aflS/pathway regulator
AFLA_139360GTGGGG/CCGGAG/CTGGAG−369/−895/−276aflR/apa-2/afl-2/transcription activator
AFLA_139370CTGGAG/CTGGGG−450/−819aflB/fas-1/fatty acid synthase beta subunit
AFLA_139380GTGGAG−116aflA/fas-2/hexA/fatty acid synthase alpha subunit
AFLA_139390No motif found aflD/nor-1/reductase
AFLA_139410GTGGCG−763aflC/pksA/pksL1/polyketide synthase
AFLA_139440No motif found aflF/norB/dehydrogenase
a: 5′-SYGGRG-3′, S: C + G, Y: C + T, R: A + G.
Table
Table 4. Effect of GA on the expression of the antioxidant-related genes in A. flavus.
Table 4. Effect of GA on the expression of the antioxidant-related genes in A. flavus.
P02-P aP08-P b
Gene NameLog2 Ratio cp ValueUp/DownSignificant eLog2 Ratio dp ValueUp/DownSignificant e
ppoC
(AFLA_030430)		−2.02680.0003downyes−1.40567.25 × 10−2downno
gprC
(AFLA_074150)		−1.42070.0703downno−1.59344.14 × 10−6downyes
gprK
(AFLA_009790)		−1.27640.3936downno−2.12669.73 × 10−4downyes
gprM
(AFLA_075000)		−2.00790.0069downyes−1.43383.74 × 10−2downyes
glutathione S-transferase
(AFLA_016400)		0.15700.9701upno1.14801.20 × 10−4upyes
glutathione S-transferase
(AFLA_023740)		0.46670.6766upno1.23552.13 × 10−3upyes
glutathione S-transferase
(AFLA_087240)		0.80370.3272upno2.01881.07 × 10−12upyes
AhpC/TSA family thioredoxin peroxidase
(AFLA_097940)		1.13840.0655upno1.21504.41 × 10−5upyes
thioredoxin reductase Trr1/Trr2
(AFLA_051770)		0.89500.2535upno1.01963.79 × 10−2upyes
a: 0.2% (w/v) GA-treated samples (P02) compared with the untreated samples (P). b: 0.8% (w/v) GA-treated samples (P08) compared with the untreated samples (P). c: The mean value of the count number of each gene in P02/in P. d: The mean value of the count number of each gene in P08/in P. e: The genes with |Log2 ratio| ≥ 1 and p value < 0.05 were considered as significantly differentially expressed, described as ‘yes’, otherwise described as ‘no’.

Share and Cite

MDPI and ACS Style

Zhao, X.; Zhi, Q.-Q.; Li, J.-Y.; Keller, N.P.; He, Z.-M. The Antioxidant Gallic Acid Inhibits Aflatoxin Formation in Aspergillus flavus by Modulating Transcription Factors FarB and CreA. Toxins 2018, 10, 270. https://doi.org/10.3390/toxins10070270

AMA Style

Zhao X, Zhi Q-Q, Li J-Y, Keller NP, He Z-M. The Antioxidant Gallic Acid Inhibits Aflatoxin Formation in Aspergillus flavus by Modulating Transcription Factors FarB and CreA. Toxins. 2018; 10(7):270. https://doi.org/10.3390/toxins10070270

Chicago/Turabian Style

Zhao, Xixi, Qing-Qing Zhi, Jie-Ying Li, Nancy P. Keller, and Zhu-Mei He. 2018. "The Antioxidant Gallic Acid Inhibits Aflatoxin Formation in Aspergillus flavus by Modulating Transcription Factors FarB and CreA" Toxins 10, no. 7: 270. https://doi.org/10.3390/toxins10070270

APA Style

Zhao, X., Zhi, Q. -Q., Li, J. -Y., Keller, N. P., & He, Z. -M. (2018). The Antioxidant Gallic Acid Inhibits Aflatoxin Formation in Aspergillus flavus by Modulating Transcription Factors FarB and CreA. Toxins, 10(7), 270. https://doi.org/10.3390/toxins10070270

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop